Presentation TCT 2025 TCT 185: The Incidence of In-Stent Restenosis Among Patients with Cancer Presenter: Akram Mahdi October 26, 2025
Presentation TCT 2025 TCT 184: Impact of Intravascular Imaging on Clinical Outcomes in Patients with In-Stent Restenosis: A Single-Centre Observational Study Presenter: Nihit Shah October 26, 2025
Presentation TCT 2025 TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents Presenter: Kornel Kakonyi October 26, 2025
Presentation TCT 2025 TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents Presenter: Rafal Adam Januszek October 26, 2025
Presentation TCT 2025 TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial Presenter: Neal S. Kleiman October 26, 2025
Presentation TCT 2025 TCT 182: Impact of Lesion Preparation Strategy on the Efficacy of Paclitaxel Coated Balloon for Coronary In-stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial Presenter: Aditya Mantha October 26, 2025
Presentation TCT 2025 TCT 181: Efficacy and Safety of Coronary Angioplasty Using a Paclitaxel-Coated vs Uncoated Balloon in Patients with In-Stent Restenosis Stratified by Restenosis Risk: A Subanalysis of the AGENT IDE Presenter: Prakriti Gaba October 26, 2025
Presentation TCT 2025 TCT 175: Contemporary Trends for the Treatment of In-Stent Restenosis in the United States: Insights from the CathPCI Registry Presenter: Jennifer Rymer October 26, 2025
Presentation TCT 2025 TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents Presenter: Haseeb Ur Rahman October 26, 2025
Presentation TCT 2025 TCT 172: Outcomes of Radiation Overlap and Margin Length in Intracoronary Brachytherapy for In-Stent Restenosis Presenter: Chloe Kharsa October 26, 2025
Presentation TCT 2025 TCT 173: Sex-Based Differences in Long-Term Outcomes Following Intravascular Brachytherapy for In-Stent Restenosis Presenter: Mangesh Kritya October 26, 2025
Presentation TCT 2025 TCT 334: Investigating the Safety and Efficacy of HydroDynamic Contrast Recanalization in In-Stent Restenosis-Related Coronary Chronic Total Occlusions Presenter: Akshitha Yarrabothula October 26, 2025
Presentation TCT 2025 TCT 176: Mid-Term Outcomes of PCI in In-Stent Restenosis versus De-Novo Lesions in an Urban Center with a Large African American Population: An Updated Retrospective Analysis Presenter: Ankit Hanmandlu October 26, 2025
Presentation TCT 2025 TCT 177: Procedural Success of Excimer Laser Coronary Angioplasty in the Setting of In-stent Restenosis: Meta Analyses Presenter: Jasvindar Singh October 26, 2025
Presentation TCT 2025 A Novel Drug-Eluting Retrievable Scaffold for Coronary In-Stent Restenosis (Reflow Medical): Early First in Human Results Presenter: Scott Harding October 26, 2025
Presentation TCT 2025 Everolimus-Coated Balloon Intervention for Patients with In-Stent Restenosis: 3-Year Clinical Results Presenter: Fernando Alfonso October 26, 2025
Presentation TCT 2025 TCT 324: In-Stent Restenosis Rates in CTO-PCI: a Call for a Hybrid Approach Presenter: Stephane G. Carlier October 26, 2025
Presentation TCT 2025 The Coated Code: Cracking the Restenosis Puzzle Presenter: Derek A. Pineda October 25, 2025
Presentation TCT 2025 TCT 1667: Acute Coronary Syndrome due to Ostial Stent Underexpansion and Acute In-Stent Restenosis Presenter: Shaan Ali Ahmed October 25, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025